Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Mallinckrodt
Dow
Johnson and Johnson
AstraZeneca

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: tofacitinib citrate

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

tofacitinib citrate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pfizer Inc XELJANZ XR tofacitinib citrate TABLET, EXTENDED RELEASE;ORAL 208246 NDA Pfizer Laboratories Div Pfizer Inc 0069-0501-14 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0501-14)
Pfizer Inc XELJANZ XR tofacitinib citrate TABLET, EXTENDED RELEASE;ORAL 208246 NDA Pfizer Laboratories Div Pfizer Inc 0069-0501-30 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0501-30)
Pfizer Inc XELJANZ XR tofacitinib citrate TABLET, EXTENDED RELEASE;ORAL 208246 NDA U.S. Pharmaceuticals 63539-501-14 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-14)
Pfizer Inc XELJANZ XR tofacitinib citrate TABLET, EXTENDED RELEASE;ORAL 208246 NDA U.S. Pharmaceuticals 63539-501-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-30)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Baxter
Harvard Business School
McKesson
McKinsey